These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 22028457

  • 21. MOG1: a new susceptibility gene for Brugada syndrome.
    Kattygnarath D, Maugenre S, Neyroud N, Balse E, Ichai C, Denjoy I, Dilanian G, Martins RP, Fressart V, Berthet M, Schott JJ, Leenhardt A, Probst V, Le Marec H, Hainque B, Coulombe A, Hatem SN, Guicheney P.
    Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
    [Abstract] [Full Text] [Related]

  • 22. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M, Nakamura K, Kusano KF, Morita H, Ohta-Ogo K, Miura D, Miura A, Nakagawa K, Tada T, Murakami M, Nishii N, Nagase S, Hata Y, Kohno K, Ouchida M, Shimizu K, Yutani C, Ohe T, Ito H.
    Cardiovasc Pathol; 2011 Jun; 20(1):e37-42. PubMed ID: 20219395
    [Abstract] [Full Text] [Related]

  • 23. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
    Hu D, Viskin S, Oliva A, Carrier T, Cordeiro JM, Barajas-Martinez H, Wu Y, Burashnikov E, Sicouri S, Brugada R, Rosso R, Guerchicoff A, Pollevick GD, Antzelevitch C.
    Heart Rhythm; 2007 Aug; 4(8):1072-80. PubMed ID: 17675083
    [Abstract] [Full Text] [Related]

  • 24. Letter by Casado-Arroyo et al regarding article, "Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization".
    Casado-Arroyo R, Rodriguez-Mañero M, Sarkozy A, Brugada P.
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):e59; author reply e60-1. PubMed ID: 22511669
    [No Abstract] [Full Text] [Related]

  • 25. New clinical and electrocardiographic classification in patients with idiopathic ventricular fibrillation.
    Sekiguchi Y, Aonuma K, Takagi M, Aihara N, Yokoyama Y, Hiraoka M, Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators.
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):902-8. PubMed ID: 23600374
    [Abstract] [Full Text] [Related]

  • 26. Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation.
    Valdivia CR, Medeiros-Domingo A, Ye B, Shen WK, Algiers TJ, Ackerman MJ, Makielski JC.
    Cardiovasc Res; 2010 Jun 01; 86(3):392-400. PubMed ID: 20042427
    [Abstract] [Full Text] [Related]

  • 27. Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome.
    Brugada R, Brugada P, Brugada J.
    J Electrocardiol; 2006 Oct 01; 39(4 Suppl):S115-8. PubMed ID: 16934827
    [Abstract] [Full Text] [Related]

  • 28. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR, Gray RA, Karasik P, Moore HJ, Singh SN.
    Europace; 2014 Nov 01; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [Abstract] [Full Text] [Related]

  • 29. Does early repolarization in the athlete have analogies with the Brugada syndrome?
    Bianco M, Bria S, Gianfelici A, Sanna N, Palmieri V, Zeppilli P.
    Eur Heart J; 2001 Mar 01; 22(6):504-10. PubMed ID: 11237546
    [Abstract] [Full Text] [Related]

  • 30. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR, Tester DJ, Rok BA, Porter CB, Munger TM, Jahangir A, Makielski JC, Ackerman MJ.
    Cardiovasc Res; 2004 Apr 01; 62(1):53-62. PubMed ID: 15023552
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of prominent J waves in patients presenting with ventricular fibrillation without structural heart disease: a single-center study.
    Ohkubo K, Watanabe I, Okumura Y, Kofune M, Nagashima K, Mano H, Sonoda K, Nakai T, Kasamaki Y, Hirayama A.
    J Cardiol; 2012 May 01; 59(3):313-20. PubMed ID: 22440686
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction.
    Bezzina CR, Shimizu W, Yang P, Koopmann TT, Tanck MW, Miyamoto Y, Kamakura S, Roden DM, Wilde AA.
    Circulation; 2006 Jan 24; 113(3):338-44. PubMed ID: 16415376
    [Abstract] [Full Text] [Related]

  • 34. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
    Baroudi G, Napolitano C, Priori SG, Del Bufalo A, Chahine M.
    Can J Cardiol; 2004 Mar 15; 20(4):425-30. PubMed ID: 15057319
    [Abstract] [Full Text] [Related]

  • 35. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill.
    Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A, Kikuchi K.
    J Intern Med; 2004 Jan 15; 255(1):137-42. PubMed ID: 14687250
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of early repolarization in short QT syndrome.
    Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K, Oda H, Itoh H, Okada M, Tanabe N, Yagihara N, Kamakura S, Horie M, Aizawa Y, Shimizu W.
    Heart Rhythm; 2010 May 15; 7(5):647-52. PubMed ID: 20206319
    [Abstract] [Full Text] [Related]

  • 37. Idiopathic ventricular fibrillation, early repolarization and other J wave-related ventricular fibrillation syndromes: from an electrocardiographic enigma to an electrophysiologic dogma.
    Nam GB.
    Circ J; 2012 May 15; 76(12):2723-31. PubMed ID: 23131759
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Air pollution effects on ventricular repolarization.
    Lux RL, Pope CA.
    Res Rep Health Eff Inst; 2009 May 15; (141):3-20; discussion 21-8. PubMed ID: 19579527
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H.
    J Cardiovasc Pharmacol; 2010 Oct 15; 56(4):389-95. PubMed ID: 20625312
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.